A randomized, open-label, multicenter, phase 3 study to compare the efficacy and safety of eribulin to treatment of physician’s choice in patients with advanced non-small cell lung cancer

類似資料

• An open-label, multicenter evaluation of the long-term safety and efficacy of risperidone in adolescents with schizophrenia
  著者:: Pandina Gahan, 等
  出版事項: (2012-06-01)
• An open-label, multicenter evaluation of the long-term safety and efficacy of risperidone in adolescents with schizophrenia
  著者:: Pandina, Gahan, 等
  出版事項: (2012)
• An assessment of the efficacy and safety of dydrogesterone in women with ovarian endometrioma: An open‐label multicenter clinical study
  著者:: Kitawaki, Jo, 等
  出版事項: (2021)
• A multicenter, open-label, efficacy, pharmacokinetic, and safety study of adalimumab in Japanese patients with ankylosing spondylitis
  著者:: Kobayashi, Shigeto, 等
  出版事項: (2011)
• Efficacy and safety of available treatments for visceral leishmaniasis in Brazil: A multicenter, randomized, open label trial
  著者:: Romero, Gustavo Adolfo Sierra, 等
  出版事項: (2017)